Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women
- PMID: 34157104
- PMCID: PMC8530718
- DOI: 10.1210/clinem/dgab461
Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women
Abstract
Context: We previously reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies.
Objective: This study assessed whether risk factors for breast cancer are correlates of AMH concentration.
Methods: This cross-sectional study included 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49) from 10 cohort studies among the general population.
Results: Adjusting for age and cohort, AMH positively associated with age at menarche (P < 0.0001) and parity (P = 0.0008) and inversely associated with hysterectomy/partial oophorectomy (P = 0.0008). Compared with women of normal weight, AMH was lower (relative geometric mean difference 27%, P < 0.0001) among women who were obese. Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P < 0.0001). We observed higher AMH concentrations among women who had had a benign breast biopsy (15% higher, P = 0.03), a surrogate for benign breast disease, an association that has not been reported. In analyses stratified by age (<40 vs ≥40), associations of AMH with body mass index and OCs were similar in younger and older women, while associations with the other factors (menarche, parity, hysterectomy/partial oophorectomy, smoking, and benign breast biopsy) were limited to women ≥40 (P-interaction < 0.05).
Conclusion: This is the largest study of AMH and breast cancer risk factors among women from the general population (not presenting with infertility), and it suggests that most associations are limited to women over 40, who are approaching menopause and whose AMH concentration is declining.
Keywords: AMH correlates; anti-Müllerian hormone; breast cancer risk factors.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures

Similar articles
-
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.Fertil Steril. 2017 Apr;107(4):1012-1022.e2. doi: 10.1016/j.fertnstert.2017.02.105. Fertil Steril. 2017. PMID: 28366409 Free PMC article.
-
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.Hum Reprod. 2016 May;31(5):1126-32. doi: 10.1093/humrep/dew044. Hum Reprod. 2016. PMID: 27094481 Free PMC article.
-
Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies.Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):854-60. doi: 10.1158/1055-9965.EPI-15-1240. Epub 2016 Mar 9. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26961996 Free PMC article.
-
A systematic review of the association between modifiable lifestyle factors and circulating anti-Müllerian hormone.Hum Reprod Update. 2024 May 2;30(3):262-308. doi: 10.1093/humupd/dmae004. Hum Reprod Update. 2024. PMID: 38402486
-
Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy.Eur J Cancer. 2017 Mar;74:1-8. doi: 10.1016/j.ejca.2016.12.008. Epub 2017 Jan 28. Eur J Cancer. 2017. PMID: 28135602 Review.
Cited by
-
Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian.Int J Gen Med. 2023 May 29;16:2047-2053. doi: 10.2147/IJGM.S410393. eCollection 2023. Int J Gen Med. 2023. PMID: 37275333 Free PMC article.
-
Oxidative Stress, Parity History, and Remnant Follicles in the Aged Ovary: Insights on Ovarian Cancer Risk and Protection.Antioxidants (Basel). 2025 Jun 20;14(7):759. doi: 10.3390/antiox14070759. Antioxidants (Basel). 2025. PMID: 40722863 Free PMC article. Review.
-
Long-term outcomes of Türkiye's first population-based mammography screening program: a decade of breast cancer detection and survival analysis in Bahçeşehir.BMC Womens Health. 2025 Jan 4;25(1):5. doi: 10.1186/s12905-024-03521-1. BMC Womens Health. 2025. PMID: 39755627 Free PMC article.
-
A contemporary review of breast cancer risk factors and the role of artificial intelligence.Front Oncol. 2024 Apr 18;14:1356014. doi: 10.3389/fonc.2024.1356014. eCollection 2024. Front Oncol. 2024. PMID: 38699635 Free PMC article. Review.
References
-
- Dólleman M, Verschuren WM, Eijkemans MJ, et al. . Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98(5):2106-2115. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA178949/CA/NCI NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- P30 CA016087/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- UM1 CA176726/CA/NCI NIH HHS/United States
- U01 CA182934/CA/NCI NIH HHS/United States
- UM1 CA182934/CA/NCI NIH HHS/United States
- P30 ES000260/ES/NIEHS NIH HHS/United States
- C570/A16491/CRUK_/Cancer Research UK/United Kingdom
- R01 HD078517/HD/NICHD NIH HHS/United States
- Z01-ES044005/ES/NIEHS NIH HHS/United States
- DH_/Department of Health/United Kingdom
- R01 CA178949/NH/NIH HHS/United States
- Z01 ES044005/ImNIH/Intramural NIH HHS/United States
- R01 CA098661/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- BBC_/Breast Cancer Now/United Kingdom
LinkOut - more resources
Full Text Sources
Medical